Literature DB >> 16406779

Ehrlichia subversion of host innate responses.

Yasuko Rikihisa1.   

Abstract

Anaplasma (formerly Ehrlichia) phagocytophilum and Ehrlichia chaffeensis, upon infection of humans, replicate in host leukocyte granulocytes and monocytes/macrophages, respectively. These unusual Gram-negative bacteria lack genes for biosynthesis of the lipopolysaccharide and peptidoglycan that activate host leukocytes. Caveolae-mediated endocytosis directs A. phagocytophilum and E. chaffeensis to an intracellular compartment secluded from oxygen-dependent and -independent killing. Furthermore, these bacteria orchestrate a remarkable series of events that culminate in suppression of NADPH oxidase, phagocyte activation and differentiation pathways, apoptosis, and interferon-gamma signaling in host leukocytes. They offer a fascinating example of how pathogens employ intricate strategies to usurp and subvert host cell function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406779     DOI: 10.1016/j.mib.2005.12.003

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  34 in total

1.  Coxiella burnetii inhibits apoptosis in human THP-1 cells and monkey primary alveolar macrophages.

Authors:  Daniel E Voth; Dale Howe; Robert A Heinzen
Journal:  Infect Immun       Date:  2007-07-02       Impact factor: 3.441

2.  Antigen display, T-cell activation, and immune evasion during acute and chronic ehrlichiosis.

Authors:  Bisweswar Nandi; Madhumouli Chatterjee; Kathryn Hogle; Maura McLaughlin; Katherine MacNamara; Rachael Racine; Gary M Winslow
Journal:  Infect Immun       Date:  2009-07-27       Impact factor: 3.441

Review 3.  Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  The prenylation inhibitor manumycin A reduces the viability of Anaplasma phagocytophilum.

Authors:  Qingming Xiong; Yasuko Rikihisa
Journal:  J Med Microbiol       Date:  2011-02-24       Impact factor: 2.472

5.  Identification of novel surface proteins of Anaplasma phagocytophilum by affinity purification and proteomics.

Authors:  Yan Ge; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2007-08-31       Impact factor: 3.490

6.  Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae.

Authors:  Qin Yang; Heather L Stevenson; Melanie J Scott; Nahed Ismail
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

Review 7.  Anaplasma phagocytophilum and Ehrlichia chaffeensis type IV secretion and Ank proteins.

Authors:  Yasuko Rikihisa; Mingqun Lin
Journal:  Curr Opin Microbiol       Date:  2010-01-05       Impact factor: 7.934

8.  Anaplasma phagocytophilum Ats-1 is imported into host cell mitochondria and interferes with apoptosis induction.

Authors:  Hua Niu; Vera Kozjak-Pavlovic; Thomas Rudel; Yasuko Rikihisa
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

9.  Anaplasma phagocytophilum increases cathepsin L activity, thereby globally influencing neutrophil function.

Authors:  Venetta Thomas; Swapna Samanta; Erol Fikrig
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

10.  Silencing of genes involved in Anaplasma marginale-tick interactions affects the pathogen developmental cycle in Dermacentor variabilis.

Authors:  Katherine M Kocan; Zorica Zivkovic; Edmour F Blouin; Victoria Naranjo; Consuelo Almazán; Ruchira Mitra; José de la Fuente
Journal:  BMC Dev Biol       Date:  2009-07-16       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.